Skip to main content
Premium Trial:

Request an Annual Quote

CytRx Subsidiary Araios Partners with 3rd Millennium on RNAi Informatics

NEW YORK, Nov. 21 (GenomeWeb News) - CytRx announced today that its subsidiary Araios, based in Worcester, Mass., will collaborate with 3rd Millennium to establish an informatics platform for RNAi-based drug development in the areas of type II diabetes and obesity.

 

CytRx scientists will use the system to generate target libraries for these two diseases. The company will also work with 3rd Millennium to build informatics infrastructure, virtual library construction, homology modeling, and virtual screening workflow for its small molecule discovery program.

 

Financial details of the collaboration were not disclosed.

 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.